-
Debate weighs whether BMI should remain central to obesity diagnosis
Francesco Rubino, MD, spoke in favor of moving beyond body mass index in diagnosing obesity. Leigh Perreault, MD, defended the long-time cornerstone of obesity diagnosis.
-
Obesity Year in Review to give an overview of major advances and discoveries
Presentations in this opening-day symposium will include a review of recent literature on the clinical application of glucagon-like peptide-1 (GLP-1)-based drugs by Julio E. Ayala, PhD, who will also identify knowledge gaps that can guide future clinical trials.
-
Presenter Profile: Age-Related Adipose Remodeling and Metabolic Dysfunction
Qiong Annabel Wang, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person 12:00 a.m., at 8:00 a.m. CT.
-
Presenter Profile: Systemic Effects of Liver Senescence in Relation to Metabolic Disease
Kuo Du, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at 8:00 a.m. CT.
-
Presenter Profile: Sexual Dimorphism in β-Cell Physiology and Susceptibility to Dysfunction
Emilyn Alejandro, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at 8:00 a.m. CT.
-
Debate to focus on BMI and definitions of obesity
Body mass index (BMI) is one of the most controversial topics in the assessment of obesity today. Session Chair Robert Kushner, MD, previews a debate on whether this metric should be the primary tool in defining obesity.
-
Presenters to provide first look at data from REIMAGINE trials of cagrilintide/semaglutide for type 2 diabetes management
John B. Buse, MD, PhD, and other researchers will share study results and a broad understanding of amylin, from the hormone’s biology to potential translation to clinical care via phase 3 trials.
-
Symposium to highlight the latest chapters in the Standards of Care for Overweight and Obesity
The American Diabetes Association® (ADA) released the first chapters of this document in 2025. Kimberly Gudzune, MD, MPH, and other speakers will explain new standards on the screening and diagnosis of obesity, and on pharmacological treatments.